Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by losingmyshirton Apr 04, 2022 8:14am

111 Views

Post# 34572290

Hey Bob Farrell, what's the excuse for this blunder

So sad that Bob does not update the people putting bread on his table.
No news ffrom him? The only news that we hear from Bob these days is when he announces additional payments to Salzman. Speaking of Salzman, he will need money again soon so you can be sure that you will hear from Bob shortly.

R107 CANADIAN TIRE TESTED!

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?